drugset / Trial / NCT04977570
A Study of SYHA1805 in Healthy Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a Phase Ib study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple-dose of SYHA1805.
Timeline
- Start
- 2021-07
- Primary completion
- 2022-05
- Completion
- 2022-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYHA1805 | Unknown | — | Oral |
Indications
No indication recorded.